Showing results (1-10 of 322) with videos related to
Sort By:
Pageof 33
Blood Cancer Discovery|February 9, 2026
First-line Therapy in Newly Diagnosed Multiple MyelomaKevin C Miller, Saad Z UsmaniOncotarget|September 20, 2012
Second primary malignancies and myeloma therapy: fad or fact?Saad Z UsmaniClinical Lymphoma, Myeloma & Leukemia|February 8, 2024
SOHO State of the Art Updates and Next Questions: Will CAR-T Replace ASCT in NDMMEric Jurgens, Saad Z UsmaniClinical Lymphoma, Myeloma & Leukemia|November 1, 2011
HSP90 inhibitors as therapy for multiple myelomaSaad Z Usmani, Gabriela ChiosisClinical Lymphoma, Myeloma & Leukemia|December 10, 2014
Novel drug combinations for the management of relapsed/refractory multiple myelomaSaad Z Usmani, Sagar LonialClinical Advances in Hematology & Oncology : H&O|September 28, 2016
The role of high-dose melphalan and autologous stem cell transplant in the rapidly evolving era of modern multiple myeloma therapyPeter M Voorhees, Saad Z UsmaniJournal of Mammary Gland Biology and Neoplasia|August 11, 2006
Multifaceted role of Rho proteins in angiogenesisSofia D Merajver, Saad Z UsmaniJournal of the National Comprehensive Cancer Network : JNCCN|December 7, 2020
Defining and Managing High-Risk Multiple Myeloma: Current ConceptsLuciano J Costa, Saad Z UsmaniCurrent Hematologic Malignancy Reports|March 22, 2020
Extramedullary Disease in Multiple MyelomaMegan H Jagosky, Saad Z UsmaniDrugs|April 12, 2022
BCMA-Targeted Biologic Therapies: The Next Standard of Care in Multiple Myeloma TherapyBarry Paul, Cesar Rodriguez, Saad Z UsmaniPageof 33